Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Capitalize on the In Vivo Toxicology Shake-Up: Benchmark Charles River, Labcorp, Evotec, WuXi AppTec and Thermo Fisher Before R&D Shifts Redraw Global Market Share

globenewswire.com
CRL Mentioned as a company to benchmark in the in vivo toxicology market, which is projected to grow. The article does not provide specific sentiment towards Charles River. EVTC Mentioned as a company to benchmark in the in vivo toxicology market, which is projected to grow. The article does not provide specific sentiment towards Evotec. TMO Mentioned as a company to benchmark in the in vivo toxicology market, which is projected to grow. The article does not provide specific sentiment towards Thermo Fisher.

Capitalize on the In Vivo Toxicology Shake-Up: Benchmark Charles River, Labcorp, Evotec, WuXi AppTec and Thermo Fisher Before R&D Shifts Redraw Global Market Share Dublin, Sept. 23, 2026 (GLOBE NEWSWIRE) -- "In Vivo Toxicology - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

The global market for In Vivo Toxicology was estimated at US$4.5 Billion in 2025 and is projected to reach US$6.0 Billion by 2032, growing at a CAGR of 4.3% from 2025 to 2032. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

What Factors Are Driving the Growth in the In Vivo Toxicology Market?

The growth in the in vivo toxicology market is driven by several factors, including the increasing demand for new drug development, stricter regulatory requirements, and technological advancements in testing methods. As pharmaceutical companies continue to develop innovative therapies, particularly in the fields of biologics and gene therapy, the need for comprehensive toxicology studies is rising. Regulatory agencies such as the FDA and EMA have implemented rigorous safety testing guidelines, driving the demand for in vivo toxicology to ensure compliance. Additionally, advancements in imaging, gene editing, and data analytics are enhancing the accuracy and efficiency of toxicology studies, further supporting market growth. Ethical considerations and the shift towards reducing animal testing are also influencing the evolution of the market.

Report Scope

The report analyzes the In Vivo Toxicology market, presented in terms of market value (US$). The analysis covers the key segments and geographic regions outlined below:

Key Insights:

Why You Should Buy This Report:

Key Questions Answered:

Report Features:

Domain Expert Insights

This market report incorporates insights from domain experts across enterprise, industry, academia, and government sectors. These insights are consolidated from multilingual multimedia sources, including text, voice, and image-based content, to provide comprehensive market intelligence and strategic perspectives. As part of this research study, the publisher tracks and analyzes insights from 4,617 domain experts. Clients may request access to the network of experts monitored for this report, along with the online expert insights tracker.

Key Attributes:

A selection of companies mentioned in this report includes, but is not limited to:

For more information about this report visit https://www.researchandmarkets.com/r/s8ouob

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.